Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Non-Current Assets (2016 - 2025)

STRATA Skin Sciences' Other Non-Current Assets history spans 15 years, with the latest figure at $231000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $231000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $231000.0, a 0.0% change, with the full-year FY2025 number at $231000.0, changed 0.0% from a year prior.
  • Other Non-Current Assets hit $231000.0 in Q4 2025 for STRATA Skin Sciences, roughly flat from $231000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SSKN hit a ceiling of $325000.0 in Q2 2024 and a floor of $71000.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $200500.0 across 5 years, with a median of $231000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 61.62% in 2023 and later skyrocketed 357.75% in 2024.
  • Tracing SSKN's Other Non-Current Assets over 5 years: stood at $216000.0 in 2021, then plummeted by 54.63% to $98000.0 in 2022, then skyrocketed by 135.71% to $231000.0 in 2023, then changed by 0.0% to $231000.0 in 2024, then changed by 0.0% to $231000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for SSKN at $231000.0 in Q4 2025, $231000.0 in Q3 2025, and $231000.0 in Q2 2025.